Serum IFN-γ and TNF-α levels in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005
Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
Elevated serum adiponectin level in patients with mycobacterium avium-intracellulare complex pulmonary disease Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
High serum CA-125 level in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 415s Year: 2005
Serum concentration of cytokines before and during treatment in patients with active tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 10s Year: 2002
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
High serum periostin levels and the association with pulmonary tuberculosis Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018
Serum leptin levels in patients with chronic airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 306s Year: 2005
Pulmonary function and levels of serum leptin and interleukin-6 in women with bronchial asthma Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018
Levels of IL-1β and TNFα production in patients with lung tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002
Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Relation of D-dimer levels and extent of disease in patients with active tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Serum and r32kd induced cytokine levels and expression in tuberculosis patients and contacts Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
Evaluation of sICAM-1 as a serum marker for follow-up of pulmonary tuberculosis therapy Source: Eur Respir J 2005; 26: Suppl. 49, 454s Year: 2005
Usefulness of serum procalcitonin levels in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 371 Year: 2011
Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002
The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010